Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome
NCT01825395
·
clinicaltrials.gov ↗
APPROVED_FOR_MARKETING
Status
OTHER
Sponsor class
Conditions
Lambert Eaton Myasthenic Syndrome
Interventions
DRUG:
3, 4-Diaminopyridine
Sponsor
University of Colorado, Denver